Acquired Hemophilia Overview

Save information for later
Sign Up

Learn About Acquired Hemophilia

What is the definition of Acquired Hemophilia?
Acquired hemophilia is a bleeding disorder that interferes with the body's blood clotting process. Signs and symptoms include prolonged bleeding, frequent nosebleeds, bruising throughout the body, solid swellings of congealed blood (hematomas), hematuria, and gastrointestinal or urologic bleeding. Acquired hemophilia occurs when the body's immune system attacks and disables a certain protein that helps the blood clot. About half of the cases are associated with other conditions, such as pregnancy, autoimmune disease, cancer, skin diseases, or allergic reactions to medications.
What are the alternative names for Acquired Hemophilia?
  • Acquired hemophilia
  • Acquired haemophilia
Who are the top Acquired Hemophilia Local Doctors?
Advanced in Acquired Hemophilia
Jaime Chavez-Garcia
Advanced in Acquired Hemophilia
Jaime Chavez-Garcia
Seguro Social, MEX, MX 
 (13.0 km)

Jaime Chavez-Garcia practices in Seguro Social, Mexico. Chavez-Garcia and is rated as an Advanced expert by MediFind in the treatment of Acquired Hemophilia. Their top areas of expertise are Acquired Hemophilia, Blood Clots, Hemophilia A, and Von Willebrand Disease (VWD).

Experienced in Acquired Hemophilia
Luis A. Hurtado-Sanchez
Experienced in Acquired Hemophilia
Luis A. Hurtado-Sanchez
Seguro Social, MEX, MX 
 (13.0 km)

Luis Hurtado-Sanchez practices in Seguro Social, Mexico. Hurtado-Sanchez and is rated as an Experienced expert by MediFind in the treatment of Acquired Hemophilia. His top areas of expertise are Acquired Hemophilia, COVID-19, Severe Acute Respiratory Syndrome (SARS), and Disseminated Intravascular Coagulation.

 
 
 
 
Learn about our expert tiers
Learn More
View All Doctors
What are the latest Acquired Hemophilia Clinical Trials?
A Multicenter, Single-arm Exploratory Study of CD38 (Daratumumab) Monoclonal Antibody (Daratumumab) Combined Corticosteroid in the Treatment of Acquired Hemophilia A (AHA)
A Multicenter, Single-arm Exploratory Study of CD38 (Daratumumab) Monoclonal Antibody (Daratumumab) Combined Corticosteroid in the Treatment of Acquired Hemophilia A (AHA)
Enrollment Status: Recruiting
Publish Date: February 21, 2025
Intervention Type: Drug
Study Phase: Phase 4

Summary: To evaluate the time of response, sustained remission rate and relapse rate of CD38 monoclonal antibody (Daratumumab) combined corticosteroid in the treatment of AHA. To evaluate the safety of CD38 monoclonal antibody in the treatment of AHA.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Emicizumab in Patients With Acquired Hemophilia A: Multicenter, Single-arm, Open-label Clinical Trial
Emicizumab in Patients With Acquired Hemophilia A: Multicenter, Single-arm, Open-label Clinical Trial
Enrollment Status: Recruiting
Publish Date: January 28, 2025
Intervention Type: Drug
Study Phase: Phase 2

Summary: This is a phase II multicenter open-label, single-arm prospective study to evaluate the efficacy of prophylactic emicizumab administered on a scheduled basis to prevent bleeds in patients with acquired hemophilia A (AHA).

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center